CVS Health has entered into a definitive agreement to acquire Signify Health, which boasts a network of more than 10,000 physicians, nurse practitioners and physician assistants that provide home-based visits.
The key priority for any healthcare system should be the well-being of patients. At present, the U.S. healthcare system is failing to target low-hanging fruit that could help drive better results for patients, and—by catching illnesses earlier—ultimately lower the cost of our healthcare system.
“We are excited to combine Bomi’s talent, expertise and capabilities with UPS Healthcare—together, we will provide unmatched solutions to our customers, powered by UPS’s integrated, global smart logistics network.”
Many younger employees need the interaction of in-person work. But to encourage a broader return to in-person work, organizations must make a compelling case for the benefits it brings employees. At the same time, they need to toss out the old office paradigm and transform to one that celebrates the new world of work.
Not talking, doing is the mantra of the medtech professionals behind Diversity by Doing (DxD), an organization committed to helping small- to mid-sized medtech companies build a foundation of diversity, equity and inclusion into their companies’ DNA.
Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks’ FFRangio System for the noninvasive diagnosis of CAD in the U.S., Europe and Japan, where it is commercially available.
Data analytics can provide a more streamlined view of your customers and simplify the complex challenges faced by medical device commercial operations teams.
Standalone best-of-breed Enterprise Asset Management (EAM) systems have historically been leveraged to help solve the transactional needs of clinical engineering, IT and facilities. Yet few organizations are currently capitalizing on the wealth of data generated from these systems. In this article, we’ll examine some of these opportunities and offers suggestions as the industry begins developing our “next generation” of EAM systems.
“M.I.Tech is an innovator in nonvascular stent development, with product offerings that complement our existing stent portfolio.”
There is capital sitting on the sidelines, but founders and CEOs should realize that investors are digging into their due diligence. The “wow” factor and potential size of the medtech market matter much less now than solid fundamentals.
